BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
o There were very few details provided within the abstract with respect to methods. Info on databases searched and analysis methods should be included. o Additionally, the first sentence of the "methods and analysis" section states that studies and reports will be identified, but it is really only cohort studies searched.
• Strengths and Limitations section: o #3 is not very relevant to this protocol. The protocol is not designed to identify treatments, therefore not a relevant limitation. o #4 This is the only mention of MCI subtypes. If not all are included in this study, which ones are? The main text should also describe the various subtypes so it is clear what exactly is being addressed in this study.
• Page 16, Line 37: Provide a reference for the sentence ending in "….only four have been approved for use." • Page 6, Line 51: Clarify, is the prevalence for the adult population?
• Page 6, Line 55: 10~15% should be changed to ~10-15% • Page 8, Line 44: Objective #2 does not appear to be an objective of this study, but rather something you home to be able to do after the study.
• Page 8, Line 49: Objective #3 is not properly worded as an objective, but it is also not described in the methods how this tool will be built. Again, this does not seem to be an objective of this review, rather a potential use after it is complete.
• Page 9, Line 4: Careful of tense used.
• Page 9, Line 15: Again, I really do not think this study should be limited to cohort study design • Page 9, Line 35: an inclusion criteria is that the study meets the criteria for normal cognition diagnosis, but no definition no normal cognition, or possible criteria, are provided.
• Page 10, Line 47: Given that you are looking to identify risk factors, I do not think it is appropriate to "describe the risk factors" in your search strategy. You may have some idea of what you will find, but you cannot be presumptive and must allow for the search strategy to capture any and all studied risk factors.
• Search Strategy: In addition to above, I do not see search terms for "normal cognition" or "onset" which could be helpful. I am also not sure why in the Cochrane Library search strategy, search #1 you provide so much focus on age, when in the inclusion criteria you specifically highlight you are interested in any age. Including search #1 using "AND" with #2 and #3 may limit the relevant articles.
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GENERAL COMMENTS
Wang and colleagues in this manuscript aimed to describe a protocol evaluating the conduction of a meta-analysis of the risk factors that predict cognitive disruption in individuals based on associations with mild cognitive impairment (MCI). This manuscript is interesting and well written and the methods appeared to be sound. However, the Authors should take into account the following minor points to improve the structure if the manuscript: 1. Introduction section: One general comment involved different prevalence of MCI in clinical-based and population-based studies (Am J Geriatr Psychiatry. 2005; 13:633-4) , given that focus on this meta-analysis will be on cohort studies, this finding should be introduced and discussed.
2. The Authors should also introduce some concepts linked to MCI different operational definitions (i.e., see recent AA-NIA criteria and DSM-5 minor neurocognitive disorders).
3. Among inclusion criteria, the Authors should specify all the MCI diagnostic criteria that will be accepted for the inclusion of the cohort studies in the meta-analysis.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1: Agustin Ruiz Thank you very much for your comments and suggestions. We have made changes in the revised manuscript according to your suggestions. All revisions have been highlighted in yellow in the texts.
Reviewer2: Jennifer Donnan Thank you very much for your comments and suggestions. We have made changes in the revised manuscript according to your suggestions. All revisions have been highlighted in green in the texts.
Reviewer comments Author responses and revisions The protocol is pertinent. Maybe the authors should reinforce the new concepts emerging from the last consensus coming from the NIA-AA Research Framework including preclinical stages of the disease in advance of MCI.
Thanks for your comments, I have taken your advice and revised the article. We have defined the term of MCI in detail according to your suggestion about referring to NIA-AA Research Framework, please see the "Background" section on page 5, lines 132-140.
Reviewer comments
Author responses and revisions General:
I would like some clarification as to why the authors chose to limit the review to only cohort studies. When considering risk factors for onset of a disease, case-control studies are appropriate design, and offers the ability to identify multiple risk factors within the same study population.
Thanks for your comments. Case-control studies can identify multiple risk factors that are not identified in the same study population. In response to this problem, we have the following considerations. In casecontrol studies, the essence of the study design is that they look backwards, from disease to putative exposure [1] . The lack of assessment of baseline cognition and the likelihood of cognitive impairment at baseline maybe lead to reduce the reliability of the conclusions. And most case-control studies were designed to limit the possibility of causal links between conditions of interest [2] . Cohort studies were designed in chronological order and over a long period of follow-up, the ability to confirm the cause of disease was stronger. The incidence rate of exposure group and non-exposure group was obtained directly, and the risk was estimated directly [1][3] . Therefore, this study takes the cohort study as the research object. According to your recommendation, conclusions in which risk factors discussed based on cohort studies and case-control studies may be inconsistent, our follow-up study will focus on this issue. Thanks for your suggestions.
[ "normal cognitive" should be changed to "normal cognition"
Thanks for your comments, I have taken your advice and revised the key word. Please see the page 2, line 42. Abstract:
1.There were very few details provided within the abstract with respect to methods. Info on databases searched and analysis methods should be included. 2.Additionally, the first sentence of the "methods and analysis" section states that studies and reports will be identified, but it is really only cohort studies searched.
1.Thanks for your comments, I have taken your advice and revised the abstract. Please see the page 3, lines 69-77. 2. Some studies have not presented "cohort study" in the text words or keywords, so, in order to obtain all possible documents, the search strategy will not limit the types of studies, and the cohort studies will be gradually selected according to the content of the article by manual screening.
Strengths and Limitations section:
#3 is not very relevant to this protocol. The protocol is not designed to identify treatments, therefore not a relevant limitation. #4 This is the only mention of MCI subtypes. If not all are included in this study, which ones are? The main text should also describe the various subtypes so it is clear what exactly is being addressed in this study.
Thanks for your comments, I have taken your advice and removed the third point. Thank you for raising this important question about the MCI types. There are mainly two types of MCI, amnestic MCI (aMCI) and nonamnestic MCI (naMCI). The purpose of this study was to assess the risk factors for MCI. We do not analysis risk factors for different types of MCI separately, so the result of this study will have some limitations in explaining the correlation of risk factors with the specific MCI typing. For details of the changes, please see the page 4, lines 93-95 and page 9, lines 237-238. Thanks for your comments, we have revised the article one by one according to your Reviewer 3: Francesco Panza, MD, PhD Thank you very much for your comments and suggestions. We have made changes in the revised manuscript according to your suggestions. All revisions have been highlighted in red in the texts.
Page 16, Line 37: Provide a reference for the sentence ending in "…. only four have been approved for use." Page 6, Line 51: Clarify, is the prevalence for the adult population? Page 6, Line 55: 10~15% should be changed to ~10-15% Page 8, Line 44: Objective #2 does not appear to be an objective of this study, but rather something you home to be able to do after the study. Page 8, Line 49: Objective #3 is not properly worded as an objective, but it is also not described in the methods how this tool will be built. Again, this does not seem to be an objective of this review, rather a potential use after it is complete. Page 9, Line 4: Careful of tense used. Page 9, Line 15: Again, I really do not think this study should be limited to cohort study design Page 9, Line 35: an inclusion criterion is that the study meets the criteria for normal cognition diagnosis, but no definition no normal cognition, or possible criteria, are provided. Page 10, Line 47: Given that you are looking to identify risk factors; I do not think it is appropriate to "describe the risk factors" in your search strategy. You may have some idea of what you will find, but you cannot be presumptive and must allow for the search strategy to capture any and all studied risk factors. In addition to above, I do not see search terms for "normal cognition" or "onset" which could be helpful. I am also not sure why in the Cochrane Library search strategy, search #1 you provide so much focus on age, when in the inclusion criteria you specifically highlight you are interested in any age. Including search #1 using "AND" with #2 and #3 may limit the relevant articles.
Thanks for your comments.
I have taken your advice and removed the search terms related to the age.
Reviewer comments
Author responses and revisions 1. Introduction section: One general comment involved different prevalence of MCI in clinicalbased and population-based studies (Am J Geriatr Psychiatry. 2005; 13:633-4), given that focus on this meta-analysis will be on cohort studies, this finding should be introduced and discussed.
1.Thanks for your comments. We have studied the literature which recommended by you, and cited some important data and conclusions of the article, please see the page 5, lines 141-146.
2.Thanks for your comments. After seeing recent AA-NIA criteria and DSM-5 minor neurocognitive disorders, we have defined this term in further detail according your suggestion, please see the "Background" section on page 5, lines 127-140. 
GENERAL COMMENTS
Thank you once again for the opportunity to review the revised version of this manuscript. The authors have addressed/clarified any comments or suggestions that I had identified.
I have only one remaining comment. In my original review I suggested that specific risk factors should not be included in the search strategy as this is what you are trying to find. Though this was addressed in the search strategy (provided in appendix) the changed description in the text does not describe what was done and still seems that risk factors were searched. Given they have such a concise strategy, it might be easier to actually provide sample search words in the main text.
